Even the FDA has to engage in a little security theater
mSystems 6 , e0104521 (2021)
It's clear GLP-1 medications are not a short-term trend, but, instead, are becoming a permanent and growing solution in health care
Empagliflozin Gastrointestinal Disorders: Constipation Infections: Necrotizing fasciitis of the perineum (Fournier's gangrene), urosepsis and pyelonephritis Metabolism and Nutrition Disorders: Ketoacidosis Renal and Urinary Disorders: Acute kidney injury Skin and Subcutaneous Tissue Disorders: Angioedema, skin reactions (e.g., rash, urticaria) 7
Sources Asserin J, et al
By mimicking the natural hormone GLP-1, semaglutide activates receptors throughout the bodyparticularly in the pancreas, brain, and gastrointestinal tractto enhance insulin secretion, suppress appetite, and delay gastric emptying